| ||||||
|
|
Treating cancer-related symptoms has become a priority for cancer treatment centers. M. D. Anderson's Department of Symptom Research is at the forefront of discovering new ways of assessing and managing the symptoms of cancer and its treatment, identifying the mechanisms that cause these symptoms, and developing new or refining existing interventions that reduce symptom severity or prevent symptom occurrence. We have developed validated symptom assessment tools for clinical and research use by health care professionals around the world. As a result of our commitment to improving symptom relief, Symptom Research has been designated a The Department of Symptom Research strives to:
Our research currently focuses on educational, behavioral and medical interventions for pain, fatigue and cognitive impairment. Laboratory and neuro-imaging studies are exploring the neurophysiological mechanisms of both pain and fatigue. Charles Cleeland, PhD, founded the Pain Research group in 1979 at the University of Wisconsin, and soon became an internationally recognized expert on the assessment and treatment of cancer pain. Dr. Cleeland and the Pain Reseach Group relocated to M. D. Anderson in 1996. In March 2002, the Pain Research Group became the Department of Symptom Research. The department integrates laboratory research to develop animal models of pain, fatigue and cognitive impairment with descriptive research and interventional trials in patients. The department has enjoyed increased visibility and grant support from federal agencies and private foundations like the World Health Organization and the American Cancer Society. We collaborate with medical specialties who confront pain in the patient population--medicine, diagnostic radiology, pharmacy, neuro-oncology, radiation oncology and nursing. Contact us: |
|
User's Guide for The Brief Pain Inventory (BPI)